Pharmacokinetics and Safety of Ertapenem in the Postpartum Period
Status:
Terminated
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The investigators are doing this study to learn more about the dosing and safety of ertapenem
in women with suspected serious infections less than 42 days from the delivery of their
infant.